Highlights
A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.
Displaying items 1-12 of 249
» View baltimoresun.com items only
1
2
3
4
5
6
7
8
9
10
11-21
•
Next >
-
FDA approves new drug for erectile dysfunction
Men now have a new option to treat erectile dysfunction. The U.S. Food and Drug Administration has approved the new drug Stendra to treat the illness that causes problems in the sex lives of 30 million men. It is the first erectile dysfunction drug in a...Tags: Physical Conditions, Pfizer Inc., Drug Trafficking, Food and Drug Administration, Jack Nicholson
-
Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline
Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...Tags: Benlysta (drug), Diabetes, Stock Market, Food and Drug Administration, Lupus
-
Consolidation wave poised to hit state's health care services, biopharma sectors
Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...Tags: Express Scripts Incorporated, Benlysta (drug), AstraZeneca Plc, Layoffs and Downsizing, Stock Market
-
Wealthy nations must follow through on disease fight
In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...Tags: Barack Obama, Native Americans, Minority Groups, India, Vaccines
-
Flu vaccine producer says it can't make all the doses it has promised
NewsdayThe company whose contaminated plant touched off last year's flu vaccine shortage said yesterday that it won't be able to make all the doses promised for the 2005-2006 influenza season, raising the possibility of another vaccine shortage this fall....Tags: Preventative Medicine, Flu, U.S. Centers for Disease Control and Prevention, Pharmaceuticals, Chiron Corporation
-
U.S. government purchases $100 million stockpile of avian flu vaccine
Sun National StaffWASHINGTON - The federal government is buying $100 million of avian flu vaccine in the first step toward building a stockpile that would protect 20 million Americans from an outbreak of the deadly virus. Coming weeks after government scientists...Tags: Bill Hall, Vaccines, Diseases and Illnesses, Preventative Medicine, Viral Diseases and Infections
-
Critical stage for biotechs
Sun StaffA number of Maryland's biotechnology companies will have prospective new drugs in their final round of clinical testing this year, a key stage for some in their efforts to fully evolve from research organizations into market-driven businesses....Tags: Medical Research, Locust Point, Technology, Flu, Children
-
MARKET PULSE: U.S. stocks on move: Vertex, Facebook, Sanderson Farms
ReutersMay 29 (Reuters) - Some U.S. stocks to watch on Tuesday: LeCroy Corp, up 55 percent premarket ** Defense equipment manufacturer Teledyne Technologies Inc said it would buy LeCroy Corp for $240.5 million in cash to add more products to its portfolio....Tags: New Products, Media Industry, Earnings Forecasts, Human Genome Sciences Inc., Vertex Pharmaceuticals Incorporated
-
Reuters Health News Summary
ReutersFollowing is a summary of current health news briefs. GSK melanoma drugs may steal market from Roche LONDON (Reuters) - Two experimental skin cancer drugs from GlaxoSmithKline - each designed to block different pathways used by tumour cells - look set...Tags: Medical Research, Alzheimer's Disease, Diabetes, Cancer, Lantus (drug)
-
Human Genome shareholder files case to restrain "poison pill"
ReutersMay 29 (Reuters) - A Human Genome Sciences shareholder has filed a lawsuit against the board and requested a Maryland court to temporarily restrain the company from using a "poison pill" in response to GlaxoSmithKline's hostile $2.6 billion takeover...Tags: Shareholders, Biotechnology, Benlysta (drug), Biotechnology Industry, Lupus
-
INSIGHT-European firms plan for Greek unrest and euro exit
Reuters* Companies prepare for civil unrest and switch to drachma * Cut Greek debts, slow investments and credit worthiness checked * Worries Greek problems may spread to other eurozone areas By David Jones LONDON, May 28 (Reuters) - British electrical...Tags: Arab Spring, Johnnie Walker, Egyptian Revolution (2011), Business, Finance
-
UPDATE 2-Takeda chases emerging market sales with Brazil buy
Reuters* Japan's top drugmaker paying up to $265 mln for Multilab * 500 mln reals upfront plus as much as 40 mln in milestones * Acquisition makes Takeda a top 10 drug company in Brazil * Takeda targets 20-25 pct of sales from emerging markets (Adds Takeda...Tags: Amgen Inc., Flu, Japan, Diabetes, Globalization
Apr 30, 2012
|Story| Baltimore Sun
Apr 19, 2012
|Story| Baltimore Sun
Apr 21, 2012
|Story| Baltimore Sun
Jun 13, 2011
|Story| Baltimore Sun
Jun 16, 2005
|Story| Baltimore Sun
Sep 16, 2005
|Story| Baltimore Sun
Jan 7, 2005
|Story| Baltimore Sun
May 29, 2012
|Story| Reuters
May 29, 2012
|Story| Reuters
May 28, 2012
|Story| Reuters
May 28, 2012
|Story| Reuters
May 25, 2012
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.
